{"id":"https://openalex.org/W2944735582","doi":"https://doi.org/10.1016/j.tranon.2019.04.009","title":"Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer","display_name":"Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer","publication_year":2019,"publication_date":"2019-05-10","ids":{"openalex":"https://openalex.org/W2944735582","doi":"https://doi.org/10.1016/j.tranon.2019.04.009","mag":"2944735582","pmid":"https://pubmed.ncbi.nlm.nih.gov/31082584","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6517847"},"language":"en","primary_location":{"id":"doi:10.1016/j.tranon.2019.04.009","doi":"https://doi.org/10.1016/j.tranon.2019.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2019.04.009","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1936523319301275/pdf","source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S1936523319301275/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046273057","display_name":"Rachael B. Rowswell-Turner","orcid":"https://orcid.org/0000-0002-8726-4628","observed_orcids":["https://orcid.org/0000-0002-8726-4628"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rachael B. Rowswell-Turner","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States. Electronic address: Rachael_Turner@urmc.rochester.edu","The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States. Electronic address: Rachael_Turner@urmc.rochester.edu","institution_ids":["https://openalex.org/I28792581"]},{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014211972","display_name":"J Rutishauser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Rutishauser","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037000390","display_name":"Kyukwang Kim","orcid":"https://orcid.org/0000-0002-0386-3712","observed_orcids":["https://orcid.org/0000-0002-0386-3712","https://orcid.org/0000-0001-5571-4949"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyu Kwang Kim","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089217769","display_name":"Negar Khazan","orcid":"https://orcid.org/0000-0002-5517-6017","observed_orcids":["https://orcid.org/0000-0002-5517-6017"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Negar Khazan","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021681429","display_name":"Umayal Sivagnanalingam","orcid":"https://orcid.org/0009-0001-9134-9114","observed_orcids":["https://orcid.org/0009-0001-9134-9114"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umayal Sivagnanalingam","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Aaron M. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron M. Jones","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060794463","display_name":"Rakesh K. Singh","orcid":"https://orcid.org/0000-0002-1124-9202","observed_orcids":["https://orcid.org/0000-0002-1124-9202"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rakesh K. Singh","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052236281","display_name":"Richard G. Moore","orcid":"https://orcid.org/0000-0001-5598-5263","observed_orcids":["https://orcid.org/0000-0001-5598-5263"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard G. Moore","raw_affiliation_strings":["The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wilmot Cancer Institute at the University of Rochester Medical Center, Rochester, NY, United States","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046273057"],"corresponding_institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"],"apc_list":{"value":2300,"currency":"USD","value_usd":2300},"apc_paid":{"value":2300,"currency":"USD","value_usd":2300},"fwci":1.1957,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.78368267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"12","issue":"7","first_page":"917","last_page":"924"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-clear-cell-carcinoma","display_name":"ovarian clear cell carcinoma","score":0.9150000214576721},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9739999771118164},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5979999899864197},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8539999723434448},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.906000018119812},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.8798959255218506},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6582898497581482},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5719417333602905},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.557680606842041},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5178639888763428},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5129375457763672},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4994237422943115},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.45007824897766113},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4439975619316101},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4202510118484497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38856932520866394},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3644059896469116},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3515925407409668},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25234031677246094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2471620738506317},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.17803123593330383},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11181628704071045},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.tranon.2019.04.009","doi":"https://doi.org/10.1016/j.tranon.2019.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2019.04.009","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1936523319301275/pdf","source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6517847","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6517847","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transl Oncol","raw_type":"Text"},{"id":"pmid:31082584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31082584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:8c62d1db61424af08d462ebaed5c3c1b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8c62d1db61424af08d462ebaed5c3c1b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Translational Oncology, Vol 12, Iss 7, Pp 917-924 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.tranon.2019.04.009","doi":"https://doi.org/10.1016/j.tranon.2019.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2019.04.009","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1936523319301275/pdf","source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8700000047683716}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2944735582.pdf","grobid_xml":"https://content.openalex.org/works/W2944735582.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1622279253","https://openalex.org/W1974091059","https://openalex.org/W1975141727","https://openalex.org/W1978070868","https://openalex.org/W1997669283","https://openalex.org/W1998203489","https://openalex.org/W2000469371","https://openalex.org/W2001877789","https://openalex.org/W2025423482","https://openalex.org/W2029635878","https://openalex.org/W2042280375","https://openalex.org/W2051165598","https://openalex.org/W2056068434","https://openalex.org/W2062289724","https://openalex.org/W2064106835","https://openalex.org/W2091107854","https://openalex.org/W2103749352","https://openalex.org/W2143271066","https://openalex.org/W2154175915","https://openalex.org/W2157133261","https://openalex.org/W2160181672","https://openalex.org/W2170204936","https://openalex.org/W2206282186","https://openalex.org/W2276686550","https://openalex.org/W2282447757","https://openalex.org/W2335844855","https://openalex.org/W2396159712","https://openalex.org/W2465367340","https://openalex.org/W2486522473","https://openalex.org/W2506186937","https://openalex.org/W2514644222","https://openalex.org/W2524730105","https://openalex.org/W2748098387","https://openalex.org/W2775590543","https://openalex.org/W4233039589"],"related_works":["https://openalex.org/W2040730600","https://openalex.org/W2108763403","https://openalex.org/W4406232751","https://openalex.org/W2325793456","https://openalex.org/W3014900382","https://openalex.org/W2018597076","https://openalex.org/W4401534135","https://openalex.org/W3207357688","https://openalex.org/W4409772670","https://openalex.org/W2811109099"],"abstract_inverted_index":{"Advanced":[0],"clear":[1],"cell":[2],"ovarian":[3],"cancer":[4,48],"(CCOC)":[5],"is":[6,19,43,150],"a":[7,12,74,131,179],"highly":[8],"fatal":[9],"malignancy":[10],"with":[11,146],"scarcity":[13],"of":[14,27,62,83,124,143,163,172],"effective":[15],"treatment":[16,180],"options.":[17],"CCOC":[18,57,95],"inherently":[20],"chemotherapy":[21,177],"resistance,":[22],"but":[23,120],"the":[24,40,81,122,141,161,170],"exact":[25],"mechanism":[26],"this":[28],"resistance":[29],"has":[30],"yet":[31,102],"to":[32,79,91,105,130,152],"be":[33],"established.":[34],"Prosurvival":[35],"signaling,":[36],"such":[37],"as":[38,178],"through":[39,97],"MAPK":[41,63,84],"cascade,":[42],"one":[44],"way":[45],"in":[46,86,93,107,156],"which":[47,65],"cells":[49],"can":[50],"evade":[51],"chemotherapy.":[52],"We":[53,71],"have":[54,72],"determined":[55],"that":[56,140],"exhibits":[58],"baseline":[59],"elevated":[60],"levels":[61],"activity,":[64],"increase":[66],"further":[67],"upon":[68],"cisplatin":[69,112,128,149],"exposure.":[70],"developed":[73],"novel":[75],"MEK":[76,125,144,173],"inhibitor,":[77],"URML-3881,":[78],"test":[80],"effect":[82],"inhibition":[85,126,145,174],"CCOC.":[87,157,183],"URML-3881":[88,147],"was":[89],"found":[90],"reduce":[92],"vitro":[94],"viability":[96],"apoptosis":[98],"and":[99,127,133,148,166,175],"proliferation":[100],"inhibition,":[101],"it":[103],"failed":[104],"induce":[106],"vivo":[108],"tumor":[109,118,135],"regression.":[110,136],"Similarly,":[111],"alone":[113,155],"had":[114],"minimal":[115],"impact":[116],"on":[117],"growth,":[119],"remarkably,":[121],"combination":[123,142,171],"led":[129],"significant":[132],"prolonged":[134],"These":[137],"studies":[138,168],"confirm":[139],"superior":[151],"either":[153],"agent":[154],"Our":[158],"data":[159],"support":[160],"design":[162],"future":[164],"preclinical":[165],"clinical":[167],"into":[169],"platinum-based":[176],"strategy":[181],"for":[182]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2019-05-16T00:00:00"}